Statement Of Financial Position [Abstract]

Neurones S.A. - Filing #5981664

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment
28 118 EUR
24 849 EUR
Right-of-use assets
32 409 EUR
33 876 EUR
Deferred tax assets
6 896 EUR
6 096 EUR
Cash and cash equivalents
326 491 EUR
297 758 EUR
Assets
725 691 EUR
676 100 EUR
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
9 711 EUR
9 711 EUR
Share premium
16 278 EUR
31 383 EUR
Equity attributable to owners of parent
378 104 EUR
355 752 EUR
Non-controlling interests
58 070 EUR
54 004 EUR
Equity
295 426 EUR
16 278 EUR
9 711 EUR
58 070 EUR
1,445,000 EUR
201,000 EUR
378 104 EUR
4 334 EUR
436 174 EUR
52 556 EUR
409 756 EUR
49 410 EUR
54 004 EUR
31 383 EUR
9 711 EUR
448,000 EUR
355 752 EUR
3 849 EUR
261 847 EUR
242 436 EUR
375 582 EUR
44 243 EUR
44 998 EUR
31 403 EUR
2 996 EUR
185,000 EUR
9 691 EUR
330 584 EUR
Equity and liabilities
725 691 EUR
676 100 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.